The House Resolution introduced by Representatives Rapp, Zimmerman, Kauffman, and others designates the week of September 21 through 28, 2025, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania. This initiative aims to raise awareness and understanding of idiopathic pulmonary fibrosis (IPF), a serious and often fatal lung disease characterized by progressive scarring of lung tissue, which severely impairs the ability to transport oxygen. The resolution highlights the urgency of addressing IPF, noting that it is frequently misdiagnosed or underdiagnosed, and that it affects over 132,000 individuals in the United States, with approximately 7,000 cases in Pennsylvania alone.

The resolution emphasizes the need for increased research, awareness, and improved detection of IPF, given that it is five times more common than cystic fibrosis and Lou Gehrig's disease, yet receives significantly less research funding. It acknowledges the critical role of organizations such as the Wescoe Foundation for Pulmonary Fibrosis and the Pennsylvania Idiopathic Pulmonary Fibrosis Support Network in supporting patients and healthcare providers. By designating this week, the resolution seeks to foster greater understanding and support for those affected by IPF, ultimately aiming to enhance diagnosis and treatment options.